BioSyent Inc. (TSXV: RX)
Canada
· Delayed Price · Currency is CAD 11.25
-0.05 (-0.44%)
Nov 21, 2024, 2:10 PM EST
BioSyent Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 7.11 | 6.46 | 5.46 | 6.28 | 3.8 | 4.37 | Upgrade
|
| Depreciation & Amortization | 0.45 | 0.43 | 0.41 | 0.42 | 0.47 | 0.24 | Upgrade
|
| Other Amortization | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.05 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 1.05 | Upgrade
|
| Stock-Based Compensation | 0.54 | 0.51 | 0.44 | 0.33 | 0.27 | 0.26 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.04 | 0.14 | 0.05 | - | 0.04 | - | Upgrade
|
| Other Operating Activities | -1.34 | -1.06 | -0.36 | -0.22 | -0.21 | -0.67 | Upgrade
|
| Change in Accounts Receivable | -0.58 | 0.24 | -0.43 | -0.96 | 0.21 | 0.12 | Upgrade
|
| Change in Inventory | -1.1 | -1.48 | -2.44 | -0.13 | 0.07 | -0.66 | Upgrade
|
| Change in Accounts Payable | 1.09 | 0.01 | 1.5 | -0.16 | 0.94 | 0.12 | Upgrade
|
| Change in Unearned Revenue | 0.08 | -0.03 | -0.15 | -0.62 | 0.84 | -0.01 | Upgrade
|
| Change in Income Taxes | 0.27 | -0.21 | 0.22 | -0.15 | 0.1 | -0.17 | Upgrade
|
| Change in Other Net Operating Assets | 0.13 | 0.01 | 0.2 | -0.15 | 0.34 | -0.35 | Upgrade
|
| Operating Cash Flow | 6.72 | 5.05 | 4.95 | 4.67 | 6.89 | 4.4 | Upgrade
|
| Operating Cash Flow Growth | 2.77% | 2.15% | 5.86% | -32.19% | 56.63% | -29.98% | Upgrade
|
| Capital Expenditures | -0.07 | -0.06 | -0.05 | -0.08 | -0.01 | -0.5 | Upgrade
|
| Sale (Purchase) of Intangibles | -4.71 | -0.12 | -0.47 | -0.01 | -0.16 | -0.23 | Upgrade
|
| Investment in Securities | 4.84 | 0.13 | -10.65 | -4.89 | 3.25 | -0.94 | Upgrade
|
| Other Investing Activities | 1.3 | 0.77 | 0.19 | 0.15 | 0.32 | 0.36 | Upgrade
|
| Investing Cash Flow | 1.49 | 0.88 | -10.79 | -4.84 | 3.39 | -1.32 | Upgrade
|
| Long-Term Debt Repaid | - | -0.17 | -0.16 | -0.15 | -0.14 | -0.02 | Upgrade
|
| Net Debt Issued (Repaid) | -0.18 | -0.17 | -0.16 | -0.15 | -0.14 | -0.02 | Upgrade
|
| Issuance of Common Stock | 0.16 | 0.07 | 0.04 | 0.01 | 0.01 | 0 | Upgrade
|
| Repurchase of Common Stock | -2.79 | -3.7 | -3.69 | -1.85 | -3.14 | -6.35 | Upgrade
|
| Common Dividends Paid | -2.04 | -1.91 | -0.48 | - | - | - | Upgrade
|
| Other Financing Activities | -0.06 | -0.07 | -0.08 | -0.09 | -0.09 | -0.02 | Upgrade
|
| Financing Cash Flow | -4.92 | -5.78 | -4.37 | -2.08 | -3.37 | -6.39 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.18 | -0.03 | 0.04 | -0.02 | -0.06 | -0.09 | Upgrade
|
| Net Cash Flow | 3.12 | 0.12 | -10.17 | -2.26 | 6.85 | -3.39 | Upgrade
|
| Free Cash Flow | 6.65 | 5 | 4.9 | 4.59 | 6.88 | 3.9 | Upgrade
|
| Free Cash Flow Growth | 1.27% | 1.91% | 6.79% | -33.29% | 76.55% | -37.66% | Upgrade
|
| Free Cash Flow Margin | 19.28% | 15.81% | 17.55% | 16.04% | 30.81% | 18.19% | Upgrade
|
| Free Cash Flow Per Share | 0.56 | 0.41 | 0.39 | 0.36 | 0.53 | 0.28 | Upgrade
|
| Cash Interest Paid | 0.07 | 0.07 | 0.08 | 0.09 | 0.09 | 0.02 | Upgrade
|
| Cash Income Tax Paid | 2.41 | 2.41 | 1.76 | 2.32 | 1.37 | 1.92 | Upgrade
|
| Levered Free Cash Flow | 1.58 | 4.08 | 3.77 | 3.15 | 6.16 | 2.85 | Upgrade
|
| Unlevered Free Cash Flow | 1.62 | 4.13 | 3.82 | 3.2 | 6.21 | 2.87 | Upgrade
|
| Change in Net Working Capital | -0.15 | 1.43 | 1.01 | 2.68 | -2.45 | 0.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.